Abstract: The present invention relates to the use of certain novel compositions from clary sage (Salvia sclarea) which are inhibitors of nuclear factor kappa B (NF-?B), oxidative stress (activation of Nerf2) and the activity of the endothelin receptor. In particular, it relates to useful enriched fractions and pharmaceutical compositions from clary sage for use in the treatment of cardiovascular and inflammatory diseases and for cancers susceptible to an inhibitor of oxidative stress (activation of Nerf2), NF-?B inhibitor and an endothelin receptor inhibitor. The present invention also relates to compositions from clary sage useful to inhibit cell proliferation and for the induction of apoptosis.
Abstract: An herbal preparation comprised of sage, thyme and cumin is found to relieve the symptoms of inflammation and smooth muscle contraction. The preparation preferably comprises sage, thyme and cumin in the proportions 0.50, 0.43 and 0.07 respectively. The symptoms of menstrual cramps and asthma are relieved by administration of the preparation.
Abstract: An herbal preparation comprised of sage, thyme and cumin is found to relieve the symptoms of inflammation and smooth muscle contraction. The preparation preferably comprises sage, thyme and cumin in the proportions 0.50, 0.43 and 0.07 respectively. The symptoms of menstrual cramps and asthma are relieved by administration of the preparation.
Abstract: The present invention relates to a composition for preventing or treating neurological diseases including an extract of Euphoria longan fruit, red sage and Gastrodia elata as an active ingredient. The composition of the present disclosure has a superior effect of inhibiting the activity of acetylcholinesterase (AChE), which hydrolyzes the neurotransmitter acetylcholine directly involved in impairment of cognitive function. In addition, the composition of the present disclosure is safe for the human body since the biologically safe extract of Euphoria longan fruit, red sage and Gastrodia elata is used as the active ingredient.
Type:
Application
Filed:
March 29, 2012
Publication date:
January 23, 2014
Applicant:
Viromed Co., Ltd.
Inventors:
Doo Suk Lee, Dong Sik Kim, Seon Hee Kim
Abstract: A composition containing Salvia officinalis for improving a person's response to thermogenesis is provided. The composition may be used in methods of administration of Salvia officinalis before exercise. The composition may also be administered with thermogenic substances before exercise or before consuming a meal to improve a person's response to thermogenesis.
Type:
Application
Filed:
April 24, 2012
Publication date:
October 24, 2013
Applicant:
NORTHERN INNOVATIONS HOLDING CORP
Inventors:
Raza Bashir, Craig Wissent, Jason Peters
Abstract: Exemplary embodiments include a composition which can be added to drinking water and consumed to promote sleep. Embodiments may combine extracts of chamomile, lavender, poppy, valerian root, sage, ginko, and/or peppermint. The composition may be found on its own and added to drinking water by the end user. Alternatively, the composition may be found already in combination with drinking water, in a single serving or in multiple servings.
Abstract: This invention is directed to an Aromatherapy compound to combat symptoms of Premenstrual Syndrome. It uniquely comprises an externally applied compound consisting of “essential oils” (highly concentrated oils extracted from plant cells for use in natural, therapeutic applications) that aid in the relief or reduction of symptoms of PMS. The compound preferably comprises equal proportions of essential oil of geranium, essential oil of clary sage, and essential oil of orange. The compound can be used “neat” (directly on the skin), however, the preferred embodiment is to add the compound to a “carrier” (a base for diluting the Aromatherapy compound) such as lotion or vegetable oil. The preferred formula is approximately 3 milliliters essential oil (1milliliter of geranium, 1 milliliter of clary sage, and 1 milliliter of orange) blended in 120 milliliters of carrier.
Abstract: An orally ingestible composition for the treatment of external personal odors can include about 35% w/w to about 50% w/w of the essential oil of lavender, about 1% w/w to about 10% w/w of the essential oil of rosemary, about 1% w/w to about 10% w/w of the essential oil of sage, and sufficient carrier medium to make up to 100% by weight.
Abstract: This invention provides a vasoprotective agent containing a plant or its extract as an effective ingredient. The plant is selected from the group consisting of rosemary, sage, geranium herb, adlai, field horsetail, bitter orange peel, fucus, burdock, dokudami, Japan pepper, Ophiopogon tuber, ginkgo, natsume and dishcloth gourd.
Abstract: A herbal hair treatments and method of making the same for protecting and strengthening hair. The herbal hair treatments and method of making the same includes mixing sage, horsetail, kelp, nettle leaf, horsetail, rosemary and mineral water to form a mixture. Heating the mixture to a full boil. Straining the mixture to form an herb liquid. Mixing into the herb liquid rosemary oil, vitamin E, castor oil and a soap to form a shampoo.
Abstract: An herbal composition is disclosed and claimed. One of the compositions disclosed includes the combination of sage leaf, red raspberry leaf, bayberry bark, capsicum pepper, damiana leaf, ginger root, licorice root, vaierian root, black cohosh root, red clover extract and kudzu root. Other compositions of the herbs are disclosed and claimed. The composition is bound in tablet form and administered orally. Alternatively, the composition is applied to the skin of the user as a cream, a patch or spray.
Abstract: An orally ingestible composition for the treatment of external personal odors can include about 35% w/w to about 50% w/w of the essential oil of lavender, about 1% w/w to about 10% w/w of the essential oil of rosemary, about 1% w/w to about 10% w/w of the essential oil of sage, and sufficient carrier medium to make up to 100% by weight.
Abstract: A method of promoting the synthesis of nerve growth factor comprising administering an effective amount of rosemary and/or sage extracts or carnosic acid and/or carnosol as an effective ingredient to a subject requiring such promotion. The present method can safely and efficiently promote the production of NGF in the living body, without being accompanied by a side effect such as a loss of a quantitative balance of hormones in the living body.
Type:
Grant
Filed:
December 1, 2000
Date of Patent:
May 21, 2002
Assignee:
Nagase & Company, Ltd.
Inventors:
Kunio Kosaka, Toshitsugu Miyazaki, Hisatomi Ito
Abstract: A hair care composition that prevents hair loss and stimulates hair growth is disclosed. The hair care composition of the present invention comprises natural ingredients including one and/or more carrier oils, one and/or more essential oils, and fragrance oil. The preferred embodiment including Shea Butter, Extra Virgin Olive oil, Jojoba oil, Vanilla fragrance oil, Peppermint essential oil, Lavender essential oil, Tea Tree essential oil, Clary Sage essential oil, and Rosemary essential oil is provided.
Abstract: The present invention is a novel nutritional product composition formulated to be used as medical foods for managing COPD. The formula comprises clary sage root extract, L-Leucine, L-Isoleucine, L-Valine and L-Glutamine. The most active chemicals that import antioxidants proprieties are Tanshinones. The composition enhances the activity of Phase 2 enzymes that deactivate and react to oxygen species and many toxins present in tobacco smoke. Preparation of highly enriched Tanshinones improved the lung function in patients with chronic asthmatic bronchitis.
Abstract: The present invention is a novel nutritional product composition, formulated to be used as medical foods for managing blood flow related problems. The formula comprises clary sage root extract highly enriched for Tanshinones L-arginine, niacin, vitamin C, Vitamin B6, vitamin B12, folate and soy isoflavones. The composition enhances the increased blood flow to the muscle mass. Tanshinone IIA is an inducer of heme oxygenase 1 and suppressor of the induction of inducible nitric oxide synthase, which could result in desirable effects on two important gaseous signaling molecules, namely carbon monoxide and nitric oxide that have significant anti-inflammatory properties.
Abstract: Sympathetic nerve-stimulating fragrant compositions with weight-loss effects, characterized by containing one or more selected from among fennel oil, grapefruit oil, pepper oil, hyssop oil, sage oil, estragon oil, eucalyptus oil, rosemary oil, cinnamon oil, clove oil, ylang ylang oil, ginger oil, geranium oil and olibanum, or one or more from among limonene, pinene, myrcene and benzyl benzoate as the active ingredients in the oils, and preferably also containing caffeine.
Abstract: Disclosed here is a method for elevating skin temperature comprising administering to a subject in need thereof a composition comprising an effective amount of one or more compounds selected from the group consisting of dihydro-?-ionol and 4-methoxystyrene. Also disclosed is a method for elevating skin temperature comprising administering to a subject in need thereof a composition comprising an effective amount of one or more compounds selected from the group consisting of dihydro-?-ionol, 4-methoxystyrene, clary sage extract, Japanese peppermint extract, juniper berry extract, and geraniol.
Abstract: Perfume ingredients and essential oils in synergistic combinations improve well-being by down-regulating arousal. This could lead to enhanced quality of life and reduced stress. The perfume compositions of the invention comprise one or more materials from each of the following groups: Group A: the essential oils lavender, lavandin, bergamot, chamomile, clary sage; Group B: 2-phenoxyethanol, 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone, benzophenone, cyclopentadecanolide, alpha-ionone, beta-ionone, para-methylacetophenone, [4-isopropylcyclohexyl]methanol. The ratio of the weight percentage based on the composition of group A materials to Group B materials lies within the range 1:9 to 9:1.
Type:
Application
Filed:
March 17, 2006
Publication date:
January 1, 2009
Inventors:
Keith Douglas Perring, John Martin Behan, David Jonathan Bradshaw, Briony Care
Abstract: Devices and methods for a palatal patch include a tablet or strip having a bioadhesive component and an active component. The bioadhesive component allows for the palatal patch to be attached to an upper palate, and for the active component to be released into the oral cavity and/or GI tract. Compositions for the active component include compositions for treatment of halitosis, anti-acids, vitamins, anti-smoking agents, and others. A composition for treatment of halitosis includes at least one of Echinacea, Lavender, Mastic Gum and Sage. A device for delivery of the palatal patch to the upper palate includes a housing and a piston, the piston having a holder for the palatal patch, and wherein the piston may be configured to move distally so as to delivery the palatal patch to the upper palate.
Type:
Application
Filed:
August 15, 2007
Publication date:
April 15, 2010
Inventors:
Michael Moshe Perez-Davidi, Nir Sterer, Ervin Itzchak Weiss, Avraham Jacob Domb